New guidelines on good distribution practices for biologics will have a significant impact on the Indian pharma sector — for good or ill. Jane Wan reports.
After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback, writes Jane Wan.
China's drug-distribution network has been a mess for years, but reforms are unveiling new opportunities for market order and growth, writes Jane Wan.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial